Healthcare >> CEO Interviews >> September 13, 2002
DR. LEONARD BELL is the principal founder of Alexion and, since 2002,
the Chief Executive Officer and a Director of the Company. From 1992 to
2001, Dr. Bell was the President, Chief Executive Officer, and a
Director of the Company. Alexion became a publicly traded company on the
NASDAQ National Market in 1996. From 1990 to 1993, Dr. Bell was an
Assistant Professor in the Department of Internal Medicine (Cardiology)
at the Yale University School of Medicine as well as an Attending
Physician at the Yale-New Haven Hospital and, from 1991-1993, an
Assistant Professor in the Department of Pathology and co-Director of
the Program in Vascular Biology at Yale Medical School. Dr. Bell was the
recipient of the Physician Scientist Award from the National Institutes
of Health. From 1986 through 1990, Dr. Bell did various postdoctoral
research and clinical training in Cardiology and Pathology at the Yale
Medical School. Dr. Bell is the recipient of various honors and awards
from academic and professional organizations and his work has resulted
in more than 45 scientific publications, invited presentations and
patent applications. Dr. Bell is a Director of The Medicines Company and
CURE and an invited Member of the State of Connecticut Governor's
Council on Economic Competitiveness and Technology. Dr. Bell received
his AB from Brown University and his MD from Yale University. Dr. Bell
received his clinical training from Yale University in internal medicine
and cardiology and is currently an Adjunct Assistant Professor of
Medicine and Pathology at Yale. Profile
is?
Dr. Bell: Alexion focuses on discovering and developing novel antibody
therapeutics that treat severe unmet medical
